pharmacie et médicaments – Fin du stock d'État de Paxlovid de Pfizer, un traitement contre la covid-19

This written question concerns the depletion of the French state's stock of Paxlovid, an antiviral treatment developed by Pfizer for COVID-19. It seeks information on the implications of this stockout for public health. The question highlights potential impacts on access to treatment for vulnerable populations and the government's strategy for managing future drug supplies.